Amgen Renews Push for Colorado Payment Cap Halt At Appeals Court

Drugmaker Amgen Inc. is asking a federal appeals court to overturn a judge’s dismissal of its lawsuit seeking to prevent Colorado’s drug affordability board from capping what health plans pay for the autoimmune treatment Enbrel.

Judge Nina Y. Wang of the US District Court for the District of Colorado improperly ruled in March that Amgen lacked standing to challenge the law allowing the Colorado Prescription Drug Affordability Board to set payment caps for some of the most expensive drugs in the state, attorneys for Amgen argued in the company’s opening appeal brief filed Friday in the US Court of Appeals ...